- Total income
- ₹5,580 Cr
- Profit
- ₹790 Cr

About Narayana Hrudayalaya Limited
Data last updated:
Narayana Hrudayalaya Limited is a public limited company based in Bangalore, Karnataka, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 19 July 2000 and has been in existence for over 26 years.
Narayana Hrudayalaya is ranked #423 on the Fortune India 500 (2025). It is part of the Nifty 500 and BSE 500 indices. Its director Kiran Mazumdar-Shaw is #102 among India's richest people (2026). Its director Devi Prasad Shetty and family are #129 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN L85110KA2000PLC027497. Its GSTIN is 29AABCN1685J1Z4 (Karnataka). The company holds 20 GST registrations, of which 11 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 539551 and NSE: NH.
The company has an authorised share capital of ₹380 Cr and a paid-up capital of ₹204.36 Cr. It was formerly known as Narayana Hrudayalaya Private Limited and Narayana Hridayalaya Private Limited. It is led by directors including Emmanuel Rupert (Managing Director) and Devi Prasad Shetty (Whole-Time Director).
Its last annual general meeting (AGM) was held on 14 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at No.258/A Bommasandra Industiral Area Anekal.T.Q.Bangalore, Karnataka, India – 562158.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹7,896.04 Cr, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹838.59 Cr (net margin 10.6%) and EBITDA of ₹1,577.79 Cr (EBITDA margin 20%). The net worth stands at ₹4,537.26 Cr (up 25.1% YoY). Total assets are valued at ₹10,657 Cr (up 69.3% YoY).
The company has about 11,546 employees on its provident fund (EPFO) records. Its group structure includes 9 subsidiaries.
The company is associated with 2 brands: Medha Analytics and Narayana Health. As per MCA filings, the company has open charges of ₹2,792 Cr and satisfied charges of ₹1,705.11 Cr on record. Court records list 70 cases involving the company, including 52 filed by the company and 18 filed against it; 27 cases are pending. The company has 28 deals on record (14 market trades, 6 secondary share transfers, 4 acquisitions), with disclosed funding of ₹606.7 Cr; the latest was in November 2025. Its 7 peer companies in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (human health activities) are compared by revenue, 3 larger and 4 smaller; the largest is Apollo Hospitals Enterprise Limited with revenue of ₹21,994 Cr. The company has 69 MSME Form 1 returns on record between 2016 and 2024, listing 4,089 overdue payments to 460 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website narayanahealth.org.
Company details
Name history
Narayana Hrudayalaya has undergone 2 name changes throughout its history. The company was previously known as Narayana Hrudayalaya Private Limited, and Narayana Hridayalaya Private Limited. The current legal name is Narayana Hrudayalaya Limited.
| Company Name | Status |
|---|---|
| Narayana Hrudayalaya Limited | Current |
| Narayana Hrudayalaya Private Limited | Previous |
| Narayana Hridayalaya Private Limited | Previous |
CIN history
Narayana Hrudayalaya has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L85110KA2000PLC027497, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85110KA2000PLC027497 | Current |
| U85110KA2000PTC027497 | Previous |
| U85110KA2000PLC027497 | Previous |
Recognitions & Rankings of Narayana Hrudayalaya
- Valuation
- ₹27,130 Cr
- #102 Kiran Mazumdar-Shaw ₹32,900 Cr
- #129 Devi Prasad Shetty & family ₹26,100 Cr
Contact details
Narayana Hrudayalaya Limited's registered office is in Bangalore, Karnataka. Its website is narayanahealth.org. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNo.258/A Bommasandra Industiral Area Anekal.T.Q.Bangalore, Karnataka, India – 562158
- IndustryHealthcare, Hospitals
To see the full contact details of Narayana Hrudayalaya Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Narayana Hrudayalaya operates two associated brands: Medha Analytics and Narayana Health. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| An AI-powered platform that enhances patient care and streamlines healthcare processes. | medha.one | |
| A chain of multi-specialty hospitals is operated in India. | narayanahealth.org |
Business activity
The main business activity of Narayana Hrudayalaya is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Narayana Hrudayalaya Limited, buy the company report.
Financials of Narayana Hrudayalaya Limited
FY 2025-26 filings availableNarayana Hrudayalaya Limited reported revenue of ₹7,896.04 Cr (up 44% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 7,896 | 5,483 | 4,890 | 4,525 | 3,701 | 2,583 | 3,128 |
| Revenue growth | +44.0% | +12.1% | +8.1% | +22.3% | +43.3% | -17.4% | - |
| EBITDA | 1,578 | 1,285 | 1,162 | 980 | 655 | 182 | 417 |
| EBITDA margin | +20.0% | +23.4% | +23.8% | +21.7% | +17.7% | +7.1% | +13.3% |
| Profit before tax | 964 | 936 | 888 | 752 | 430 | (56.06) | 161 |
| Net profit | 839 | 788 | 788 | 598 | 349 | (7.99) | 130 |
| Net profit margin | +10.6% | +14.4% | +16.1% | +13.2% | +9.4% | -0.3% | +4.1% |
| EPS (₹) | 39.42 | 38.66 | 38.62 | 29.67 | 16.73 | (0.70) | 5.82 |
| Balance sheet | |||||||
| Total assets | 10,657 | 6,296 | 4,749 | 3,257 | 2,456 | 2,206 | 2,367 |
| Net worth | 4,537 | 3,626 | 2,884 | 2,131 | 1,489 | 1,120 | 1,136 |
| Total debt | 5,858 | 2,428 | 1,627 | 884 | 723 | 826 | 952 |
| Cash & bank | 2,129 | 647 | 416 | 380 | 172 | 132 | 115 |
| Net working capital | 2,031 | 664 | 278 | 224 | 154 | 4.05 | 47.83 |
| Cash flow | |||||||
| Cash from operations | 1,621 | 986 | 1,067 | 1,085 | 485 | 304 | 443 |
| Cash from investing | (3,648) | (1,325) | (1,458) | (1,176) | (267) | (113) | (189) |
| Cash from financing | 2,340 | 544 | 488 | 87.74 | (159) | (194) | (247) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,684 | 2,594 | 2,151 | 1,644 | 1,507 | 1,475 | 1,335 | 1,367 |
| Revenue growth (YoY) | +78.1% | +75.8% | +61.2% | +20.3% | +15.4% | - | - | - |
| Other income | 35.48 | 29.23 | 23.21 | 24.20 | 24.45 | 27.89 | 18.29 | 23.51 |
| EBITDA | 468 | 504 | 313 | 401 | 337 | 349 | 307 | 308 |
| EBITDA margin | +17.4% | +19.4% | +14.6% | +24.4% | +22.3% | +23.7% | +23.0% | +22.6% |
| Depreciation | 156 | 154 | 122 | 87.48 | 84.30 | 82.50 | 69.58 | 64.74 |
| Interest | 86.80 | 91.29 | 65.03 | 42.26 | 45.16 | 40.68 | 36.58 | 35.13 |
| Profit before tax | 260 | 288 | 149 | 296 | 232 | 254 | 219 | 232 |
| Tax | 53.12 | 64.10 | 22.27 | 37.19 | 34.79 | 56.78 | 25.91 | 33.17 |
| Net profit | 207 | 224 | 127 | 258 | 197 | 197 | 193 | 199 |
| EPS (₹) | 10.20 | 11.02 | 6.24 | 12.72 | 9.68 | 9.71 | 9.50 | 9.76 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 3,975 | 3,590 | 3,266 | 2,965 | 2,412 | 1,655 | 2,239 |
| Revenue growth | +10.7% | +9.9% | +10.1% | +22.9% | +45.8% | -26.1% | - |
| EBITDA | 806 | 682 | 606 | 488 | 263 | (26.12) | 263 |
| EBITDA margin | +20.3% | +19.0% | +18.6% | +16.5% | +10.9% | -1.6% | +11.7% |
| Profit before tax | 652 | 557 | 503 | 395 | 205 | (121) | 104 |
| Net profit | 530 | 419 | 422 | 259 | 135 | (73.67) | 69.75 |
| Net profit margin | +13.3% | +11.7% | +12.9% | +8.7% | +5.6% | -4.5% | +3.1% |
| EPS (₹) | 24.62 | 21.10 | 20.77 | 13.00 | 6.54 | (3.85) | 3.31 |
| Balance sheet | |||||||
| Total assets | 4,719 | 3,877 | 2,927 | 2,175 | 1,815 | 1,700 | 1,837 |
| Net worth | 2,597 | 2,186 | 1,840 | 1,469 | 1,225 | 1,090 | 1,166 |
| Total debt | 1,970 | 1,595 | 1,011 | 644 | 533 | 551 | 607 |
| Cash & bank | 424 | 386 | 232 | 198 | 113 | 56.19 | 52.27 |
| Net working capital | 278 | 205 | 19.45 | (22.11) | (37.75) | (101) | (43.43) |
| Cash flow | |||||||
| Cash from operations | 759 | 523 | 542 | 516 | 246 | 123 | 286 |
| Cash from investing | (960) | (755) | (761) | (621) | (117) | (11.81) | (129) |
| Cash from financing | 134 | 391 | 237 | 64.77 | (56.61) | (114) | (170) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,097 | 1,044 | 969 | 1,019 | 943 | 919 | 865 | 934 |
| Revenue growth (YoY) | +16.3% | +13.6% | +12.0% | +9.1% | +8.2% | - | - | - |
| Other income | 30.41 | 127 | 15.85 | 17.09 | 16.44 | 107 | 8.65 | 13.20 |
| Total expenses | 858 | 817 | 809 | 790 | 764 | 743 | 708 | 752 |
| EBITDA | 239 | 227 | 159 | 229 | 179 | 176 | 157 | 183 |
| EBITDA margin | +21.8% | +21.7% | +16.5% | +22.5% | +19.0% | +19.1% | +18.1% | +19.5% |
| Depreciation | 48.15 | 50.71 | 46.94 | 46.27 | 47.56 | 45.83 | 42.58 | 41.50 |
| Interest | 33.67 | 38.78 | 29.13 | 28.58 | 30.62 | 25.57 | 21.29 | 20.45 |
| Profit before tax | 188 | 264 | 99.27 | 171 | 117 | 211 | 101 | 134 |
| Tax | 49.87 | 62.06 | 23.52 | 33.42 | 29.90 | 51.05 | 22.22 | 28.24 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,684 | 2,594 | 2,151 | 1,644 | 1,507 | 1,475 | 1,335 | 1,367 |
| Revenue growth (YoY) | +78.1% | +75.8% | +61.2% | +20.3% | +15.4% | - | - | - |
| Other income | 35.48 | 29.23 | 23.21 | 24.20 | 24.45 | 27.89 | 18.29 | 23.51 |
| EBITDA | 468 | 504 | 313 | 401 | 337 | 349 | 307 | 308 |
| EBITDA margin | +17.4% | +19.4% | +14.6% | +24.4% | +22.3% | +23.7% | +23.0% | +22.6% |
| Depreciation | 156 | 154 | 122 | 87.48 | 84.30 | 82.50 | 69.58 | 64.74 |
| Interest | 86.80 | 91.29 | 65.03 | 42.26 | 45.16 | 40.68 | 36.58 | 35.13 |
| Profit before tax | 260 | 288 | 149 | 296 | 232 | 254 | 219 | 232 |
| Tax | 53.12 | 64.10 | 22.27 | 37.19 | 34.79 | 56.78 | 25.91 | 33.17 |
| Net profit | 207 | 224 | 127 | 258 | 197 | 197 | 193 | 199 |
| EPS (₹) | 10.20 | 11.02 | 6.24 | 12.72 | 9.68 | 9.71 | 9.50 | 9.76 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 7,896 | 5,483 | 4,890 | 4,525 | 3,701 | 2,583 | 3,128 |
| Revenue growth | +44.0% | +12.1% | +8.1% | +22.3% | +43.3% | -17.4% | - |
| Other income | 100 | 92.85 | 78.40 | 65.45 | 34.56 | 27.49 | 23.76 |
| Total expenses | 6,318 | 4,198 | 3,728 | 3,544 | 3,046 | 2,401 | 2,711 |
| Employee cost | 1,803 | 1,093 | 982 | 879 | 768 | 627 | 674 |
| EBITDA | 1,578 | 1,285 | 1,162 | 980 | 655 | 182 | 417 |
| EBITDA margin | +20.0% | +23.4% | +23.8% | +21.7% | +17.7% | +7.1% | +13.3% |
| Depreciation | 448 | 278 | 241 | 210 | 183 | 184 | 186 |
| Interest | 266 | 163 | 112 | 84.09 | 76.09 | 82.35 | 93.84 |
| Profit before tax | 964 | 936 | 888 | 752 | 430 | (56.06) | 161 |
| Tax | 158 | 146 | 98.01 | 145 | 87.66 | (41.78) | 42.25 |
| Net profit | 839 | 788 | 788 | 598 | 349 | (7.99) | 130 |
| Net profit margin | +10.6% | +14.4% | +16.1% | +13.2% | +9.4% | -0.3% | +4.1% |
| EPS (₹) | 39.42 | 38.66 | 38.62 | 29.67 | 16.73 | (0.70) | 5.82 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
| Reserves & surplus | 4,334 | 3,423 | 2,681 | 1,928 | 1,286 | 917 | 933 |
| Shareholders' funds (net worth) | 4,537 | 3,626 | 2,884 | 2,131 | 1,489 | 1,120 | 1,136 |
| Minority interest | 2.26 | 1.88 | 1.41 | 1.05 | 0.73 | 0.54 | 0.53 |
| Secured loans | 3,877 | 1,176 | 917 | 637 | 437 | 521 | 710 |
| Unsecured loans | 1,981 | 1,252 | 710 | 248 | 286 | 304 | 242 |
| Total debt | 5,858 | 2,428 | 1,627 | 884 | 723 | 826 | 952 |
| Total liabilities | 10,657 | 6,296 | 4,749 | 3,257 | 2,456 | 2,206 | 2,367 |
| Assets | |||||||
| Gross block | 9,812 | 5,930 | 4,114 | 3,663 | 3,155 | 2,982 | 2,943 |
| Net block | 7,796 | 4,266 | 2,651 | 2,336 | 1,980 | 1,961 | 2,092 |
| Capital work in progress | 292 | 85.92 | 514 | 259 | 66.93 | 19.91 | 11.78 |
| Investments | 573 | 1,084 | 844 | 252 | 132 | 120 | 86.35 |
| Inventories | 174 | 124 | 124 | 85.46 | 73.55 | 58.57 | 72.35 |
| Sundry debtors | 656 | 555 | 422 | 432 | 437 | 279 | 262 |
| Cash & bank balances | 2,129 | 647 | 416 | 380 | 172 | 132 | 115 |
| Loans & advances | 578 | 257 | 158 | 160 | 109 | 96.71 | 79.83 |
| Total current assets | 3,537 | 1,583 | 1,120 | 1,056 | 792 | 566 | 529 |
| Total current liabilities | 1,506 | 919 | 842 | 832 | 638 | 562 | 481 |
| Net working capital | 2,031 | 664 | 278 | 224 | 154 | 4.05 | 47.83 |
| Total assets | 10,657 | 6,296 | 4,749 | 3,257 | 2,456 | 2,206 | 2,367 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 447 | 242 | 145 | 149 | 89.51 | 91.84 | 84.35 |
| Net cash from operating activities | 1,621 | 986 | 1,067 | 1,085 | 485 | 304 | 443 |
| Net cash from investing activities | (3,648) | (1,325) | (1,458) | (1,176) | (267) | (113) | (189) |
| Net cash from financing activities | 2,340 | 544 | 488 | 87.74 | (159) | (194) | (247) |
| Net change in cash | 313 | 205 | 97.15 | (3.93) | 59.02 | (2.34) | 7.49 |
| Closing cash | 2,129 | 647 | 416 | 380 | 172 | 132 | 115 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +44.0% | +12.1% | +8.1% | +22.3% | +43.3% | -17.4% | - |
| EBITDA growth | +22.8% | +10.6% | +18.6% | +49.7% | +259.1% | -56.3% | - |
| PBT growth | +3.0% | +5.5% | +18.1% | +74.9% | +9998.0% | - | +72.7% |
| Net income growth | +6.5% | -0.1% | +31.7% | +71.5% | +4468.1% | -106.2% | - |
| Revenue CAGR (3Y) | +20.4% | +14.0% | +23.7% | +13.1% | +9.0% | +4.2% | +18.5% |
| EBITDA CAGR (3Y) | +17.2% | +25.2% | +85.4% | +33.0% | +30.5% | -5.2% | +21.4% |
| Profitability & leverage | |||||||
| Net income margin | +10.2% | +14.4% | +16.2% | +13.4% | +9.2% | -0.6% | +3.8% |
| Return on capital employed | +14.5% | +19.9% | +25.0% | +29.3% | +21.7% | +1.4% | +11.3% |
| Return on net worth | +19.8% | +24.3% | +31.5% | +33.5% | +26.2% | -0.7% | +10.7% |
| Debt / equity | 1.01 | 0.62 | 0.50 | 0.44 | 0.59 | 0.79 | 0.80 |
| Long-term debt / equity | 0.94 | 0.54 | 0.41 | 0.35 | 0.48 | 0.66 | 0.70 |
| Interest cover | 23.53 | 16.23 | 12.13 | 10.92 | 16.14 | -6,862.50 | 40.56 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.00 | 1.09 | 1.26 | 1.33 | 1.21 | 0.87 | 1.15 |
| Inventory turnover | 53.05 | 44.28 | 46.73 | 56.91 | 56.03 | 39.46 | 38.39 |
| Debtors turnover | 13.04 | 11.22 | 11.46 | 10.42 | 10.35 | 9.55 | 11.83 |
| EPS (₹) | 39.42 | 38.66 | 38.62 | 29.67 | 16.73 | (0.70) | 5.82 |
| Dividend per share (₹) | 4.50 | 4.50 | 4.00 | 2.50 | 1.00 | 0.00 | 1.00 |
| Book value per share (₹) | 222.08 | 177.51 | 141.17 | 104.36 | 72.91 | 54.89 | 55.66 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,097 | 1,044 | 969 | 1,019 | 943 | 919 | 865 | 934 |
| Revenue growth (YoY) | +16.3% | +13.6% | +12.0% | +9.1% | +8.2% | - | - | - |
| Other income | 30.41 | 127 | 15.85 | 17.09 | 16.44 | 107 | 8.65 | 13.20 |
| Total expenses | 858 | 817 | 809 | 790 | 764 | 743 | 708 | 752 |
| EBITDA | 239 | 227 | 159 | 229 | 179 | 176 | 157 | 183 |
| EBITDA margin | +21.8% | +21.7% | +16.5% | +22.5% | +19.0% | +19.1% | +18.1% | +19.5% |
| Depreciation | 48.15 | 50.71 | 46.94 | 46.27 | 47.56 | 45.83 | 42.58 | 41.50 |
| Interest | 33.67 | 38.78 | 29.13 | 28.58 | 30.62 | 25.57 | 21.29 | 20.45 |
| Profit before tax | 188 | 264 | 99.27 | 171 | 117 | 211 | 101 | 134 |
| Tax | 49.87 | 62.06 | 23.52 | 33.42 | 29.90 | 51.05 | 22.22 | 28.24 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 3,975 | 3,590 | 3,266 | 2,965 | 2,412 | 1,655 | 2,239 |
| Revenue growth | +10.7% | +9.9% | +10.1% | +22.9% | +45.8% | -26.1% | - |
| Other income | 176 | 142 | 123 | 101 | 106 | 75.81 | 24.14 |
| Total expenses | 3,169 | 2,908 | 2,659 | 2,477 | 2,149 | 1,681 | 1,976 |
| Employee cost | 705 | 688 | 624 | 566 | 504 | 403 | 449 |
| EBITDA | 806 | 682 | 606 | 488 | 263 | (26.12) | 263 |
| EBITDA margin | +20.3% | +19.0% | +18.6% | +16.5% | +10.9% | -1.6% | +11.7% |
| Depreciation | 191 | 169 | 161 | 139 | 119 | 123 | 128 |
| Interest | 139 | 98.41 | 64.84 | 55.17 | 45.21 | 47.78 | 55.42 |
| Profit before tax | 652 | 557 | 503 | 395 | 205 | (121) | 104 |
| Tax | 149 | 126 | 78.93 | 129 | 71.91 | (42.31) | 36.26 |
| Net profit | 530 | 419 | 422 | 259 | 135 | (73.67) | 69.75 |
| Net profit margin | +13.3% | +11.7% | +12.9% | +8.7% | +5.6% | -4.5% | +3.1% |
| EPS (₹) | 24.62 | 21.10 | 20.77 | 13.00 | 6.54 | (3.85) | 3.31 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
| Reserves & surplus | 2,393 | 1,981 | 1,637 | 1,266 | 1,022 | 887 | 963 |
| Shareholders' funds (net worth) | 2,597 | 2,186 | 1,840 | 1,469 | 1,225 | 1,090 | 1,166 |
| Secured loans | 1,039 | 676 | 506 | 459 | 314 | 331 | 418 |
| Unsecured loans | 931 | 919 | 505 | 185 | 219 | 221 | 190 |
| Total debt | 1,970 | 1,595 | 1,011 | 644 | 533 | 551 | 607 |
| Total liabilities | 4,719 | 3,877 | 2,927 | 2,175 | 1,815 | 1,700 | 1,837 |
| Assets | |||||||
| Gross block | 3,689 | 3,479 | 2,559 | 2,314 | 1,954 | 1,840 | 1,819 |
| Net block | 2,434 | 2,325 | 1,480 | 1,358 | 1,094 | 1,070 | 1,159 |
| Capital work in progress | 234 | 43.29 | 33.80 | 31.76 | 23.34 | 5.13 | 2.65 |
| Investments | 1,087 | 1,166 | 1,021 | 678 | 661 | 645 | 619 |
| Inventories | 43.73 | 46.70 | 58.44 | 34.05 | 31.70 | 24.91 | 36.09 |
| Sundry debtors | 325 | 249 | 190 | 177 | 173 | 154 | 147 |
| Cash & bank balances | 424 | 386 | 232 | 198 | 113 | 56.19 | 52.27 |
| Loans & advances | 145 | 93.16 | 69.59 | 92.09 | 65.74 | 54.72 | 54.38 |
| Total current assets | 938 | 775 | 550 | 501 | 384 | 290 | 290 |
| Total current liabilities | 660 | 570 | 531 | 523 | 422 | 392 | 333 |
| Net working capital | 278 | 205 | 19.45 | (22.11) | (37.75) | (101) | (43.43) |
| Total assets | 4,719 | 3,877 | 2,927 | 2,175 | 1,815 | 1,700 | 1,837 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 248 | 89.01 | 70.25 | 110 | 38.11 | 40.76 | 52.90 |
| Net cash from operating activities | 759 | 523 | 542 | 516 | 246 | 123 | 286 |
| Net cash from investing activities | (960) | (755) | (761) | (621) | (117) | (11.81) | (129) |
| Net cash from financing activities | 134 | 391 | 237 | 64.77 | (56.61) | (114) | (170) |
| Net change in cash | (67.71) | 159 | 18.76 | (40.20) | 72.34 | (2.65) | (12.14) |
| Closing cash | 424 | 386 | 232 | 198 | 113 | 56.19 | 52.27 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +10.7% | +9.9% | +10.1% | +22.9% | +45.8% | -26.1% | - |
| EBITDA growth | +18.2% | +12.5% | +24.2% | +85.5% | +1107.4% | -109.9% | - |
| PBT growth | +17.1% | +10.6% | +27.6% | +92.0% | +9998.0% | - | +31.0% |
| Net income growth | +26.7% | -0.7% | +63.0% | +91.2% | +283.6% | -205.6% | - |
| Revenue CAGR (3Y) | +10.3% | +14.2% | +25.4% | +9.8% | +5.1% | -3.6% | +10.8% |
| EBITDA CAGR (3Y) | +18.2% | +37.4% | - | +22.9% | +10.4% | - | +7.0% |
| Profitability & leverage | |||||||
| Net income margin | +12.7% | +12.0% | +13.0% | +9.0% | +5.5% | -4.8% | +3.0% |
| Return on capital employed | +18.4% | +19.3% | +22.3% | +22.5% | +14.3% | -4.1% | +9.0% |
| Return on net worth | +21.0% | +21.4% | +25.7% | +19.7% | +11.5% | -7.0% | +5.8% |
| Debt / equity | 0.75 | 0.65 | 0.50 | 0.44 | 0.47 | 0.51 | 0.47 |
| Long-term debt / equity | 0.69 | 0.58 | 0.43 | 0.36 | 0.39 | 0.45 | 0.43 |
| Interest cover | 22.64 | 19.18 | 14.57 | 15.81 | 31.33 | -32.06 | 40.97 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 1.11 | 1.19 | 1.34 | 1.39 | 1.27 | 0.90 | 1.35 |
| Inventory turnover | 87.92 | 68.29 | 70.62 | 90.20 | 85.21 | 54.25 | 51.10 |
| Debtors turnover | 13.84 | 16.35 | 17.81 | 16.93 | 14.71 | 10.98 | 14.73 |
| EPS (₹) | 24.62 | 21.10 | 20.77 | 13.00 | 6.54 | (3.85) | 3.31 |
| Dividend per share (₹) | 4.50 | 4.50 | 4.00 | 2.50 | 1.00 | 0.00 | 1.00 |
| Book value per share (₹) | 127.10 | 106.95 | 90.11 | 71.93 | 60.02 | 53.39 | 57.12 |
To see the full year-wise statements and ratios of Narayana Hrudayalaya Limited, buy the company report.
Board of directors of Narayana Hrudayalaya Limited
Narayana Hrudayalaya has 10 current directors and 26 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Emmanuel Rupert | Managing Director | 03 Feb 2019 | 7 Years 9 Months | Current |
| Terri Smith Bresenham Also directs: Tata Medical and Diagnostics Limited | Director | 05 Aug 2021 | 5 Years 3 Months | Current |
| Devi Prasad Shetty Also directs: Meridian Medical Research & Hospital Ltd., Medha AI Private Limited, Narayana Health Insurance Limited and 5 more | Whole-Time Director | 29 Aug 2015 | 11 Years 2 Months | Current |
| Viren Prasad Shetty Also directs: Meridian Medical Research & Hospital Ltd., Medha AI Private Limited, Narayana Health Insurance Limited and 5 more | Whole-Time Director | 29 Aug 2015 | 11 Years 2 Months | Current |
| Kiran Mazumdar Shaw | Director | 06 Feb 2008 | 18 Years 9 Months | Current |
| Nachiket Mor Also directs: Dr. Agarwal's Health Care Limited, Navi Amc Limited, Navi General Insurance Limited and 3 more | Director | 08 Feb 2023 | 3 Years 9 Months | Current |
Peer comparison
Narayana Hrudayalaya Limited is compared with the 7 companies closest to it by revenue in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹21,994 Cr (FY 2025) | 15.0% | Chennai, Tamil Nadu, India | |||
| Narayana Hrudayalaya Limitedthis company | ₹7,896.04 Cr (FY 2026) | ₹838.59 Cr | 10.6% | 44.0% | 11,546 | Bangalore, Karnataka, India |
| Fortis Healthcare Limited | ₹7,849.69 Cr (FY 2025) | 13.0% | Mohali, Punjab, India | |||
| Max Healthcare Institute Limited | ₹7,184.1 Cr (FY 2025) | 29.0% | Mumbai, Maharashtra, India | |||
| Aster DM Quality Care Limited | ₹4,286.69 Cr (FY 2025) | 15.0% | Hyderabad, Telangana, India | |||
| Fortis Hospitals Limited | ₹4,219.85 Cr (FY 2025) | 15.0% | New Delhi, Delhi, India | |||
| Yashoda Healthcare Services Limited | ₹3,399.07 Cr (FY 2025) | 9.0% | Hyderabad, Telangana, India | |||
| Krishna Institute of Medical Sciences Limited | ₹3,067 Cr (FY 2025) | 22.0% | Telangana, India |
To see the full peer comparison of Narayana Hrudayalaya Limited, buy the company report.
Auditor
Narayana Hrudayalaya Limited is audited by DELOITTE HASKINS & SELLS LLP for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DELOITTE HASKINS & SELLS LLP | FY 2025 | 117366W/W-100018 |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 63.30%, foreign institutional investors hold 9.40%, domestic institutional investors hold 9.00% and retail and other public shareholders hold 18.30%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 63.30% | 63.30% | 63.30% | 63.80% |
| Public | 36.70% | 36.70% | 36.70% | 36.20% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Mar 2026 | 101269760 | Others | ₹300 Cr | Open | |
| 19 Jan 2026 | 101226446 | Others | ₹200 Cr | Open | |
| 20 Nov 2025 | 101194399 | The Hongkong and Shanghai Banking Corporation Limited | ₹100 Cr | Open | |
| 20 Nov 2025 | 101194410 | The Hongkong and Shanghai Banking Corporation Limited | ₹100 Cr | Open | |
| 05 Nov 2025 | 101186952 | The Hongkong and Shanghai Banking Corporation Limited | ₹150 Cr | Open |
To see the full charge records of Narayana Hrudayalaya Limited, buy the company report.
Total charge records: 59 View all charges
Deals & funding
Narayana Hrudayalaya Limited has 28 deals on record (14 market trades, 6 secondary share transfers, 4 acquisitions), with disclosed funding of ₹606.7 Cr; the latest was in November 2025.
Deals on record (5 of 28)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2025 | Market trade | ₹226.51 Cr | Buyer: Graviton Research Capital LLP Seller: Graviton Research Capital LLP |
| Mar 2025 | Market trade | ₹217.52 Cr | Buyer: Graviton Research Capital LLP Seller: Graviton Research Capital LLP |
| Mar 2023 | Acquisition | ₹10 Cr | Buyer: NH Integrated Care Private Limited Seller: Narayana Hrudayalaya Limited |
| Jan 2021 | Acquisition | ₹4.52 Cr | Buyer: IQ City Foundation Seller: Narayana Hrudayalaya Limited |
| Apr 2016 | Acquisition | Undisclosed | Buyer: Chandramma Educational Society Seller: Narayana Hrudayalaya Limited |
To see the full deal history of Narayana Hrudayalaya Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Narayana Hrudayalaya Limited has 70 court cases on record: 52 filed by Narayana Hrudayalaya, 18 filed against it. 27 cases are pending and 43 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 49 | 12 | 14 |
| District courts | 19 | 5 | 12 |
| Supreme Court | 2 | 1 | 1 |
Cases on record (5 of 70)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (0901-Civil Law : SLPs arising out of interlocutory applications in civil proceedings, amendment of pleadings, time limits for pleadings, interim injunction, addition/deletion of parties, etc.) | Filed against the company by an individual | Pending |
| High Court of Karnataka | Writ petition | Filed against the company by Dtwelve Accommodations Private Limited and 1 other | Disposed |
| High Court of Karnataka | Writ petition | Filed against the company by Nazarbad Medical Services P Ltd | Disposed |
| District court, BENGALURU RURAL, Karnataka | Court case (Com.O.S.) | Filed against the company by Dtwelve Accomodation Pvt Ltd | Pending |
| District court, South Twenty Four Parganas, West Bengal | Civil suit | Filed against the company by an individual | Pending |
To see the full case history of Narayana Hrudayalaya Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Narayana Hrudayalaya Limited was last rated by Icra on 15 Apr 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 15 Apr 2021 |
To see the full credit ratings and regulatory alerts of Narayana Hrudayalaya Limited, buy the company report.
MSME payment delays
Narayana Hrudayalaya Limited has 69 MSME Form 1 returns on record between 2016 and 2024, listing 4,089 overdue payments to 460 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 460)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Ankur Media Private Limited | |||
| Andand Brand Partners Private Limited | |||
| Designtree Service Consultants Private Limited | |||
| Pocl Medical Solutions | |||
| an individual supplier |
To see the full MSME payment records of Narayana Hrudayalaya Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Narayana Hrudayalaya has 9 subsidiary companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Medha AI Private Limited | U62099KA2023PTC182294 | |
| Narayana Health Insurance Limited | U65120KA2023PLC174002 | |
| Athma Healthtech Private Limited | U72200KA2022PTC162014 | |
| Narayana Hrudayalaya Surgical Hospital Private Limited | U85100KA2010PTC055453 | |
| Narayana Hospitals Private Limited | U85110KA2004PTC033913 | |
| Narayana Vaishno Devi Specialty Hospitals Private Limited | U85110KA2014PTC076218 |
To see the full group structure of Narayana Hrudayalaya Limited, buy the company report.
Employees & EPFO
Narayana Hrudayalaya Limited has a workforce of 11,546 employees on its EPFO records as of May 2026, across 16 active EPFO establishments.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 11,546 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Narayana Hrudayalaya Limited, buy the company report.
GST
Narayana Hrudayalaya has 20 GST registrations: 11 active and 9 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCN1685J1Z4 | Karnataka | Active | 01 Jul 2017 |
| 29AABCN1685J4Z1 | Karnataka | Active | 01 Mar 2024 |
| 08AABCN1685J1Z8 | Rajasthan | Active | 01 Jul 2017 |
| 18AABCN1685J1Z7 | Assam | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Narayana Hrudayalaya Limited, buy the company report.
Recent activity
Narayana Hrudayalaya Limited has 54 board changes on record since 2000: 33 appointments and 21 cessations. The latest: Anesh Shetty was appointed as Director on 15 Jun 2024.
167 earlier events are in the company report.
News
Frequently asked questions
Narayana Hrudayalaya is an active public limited company based in Bangalore, Karnataka, India. The company works in hospitals, within the healthcare industry. It was incorporated on 19 July 2000 (26+ years old) and is registered under CIN L85110KA2000PLC027497. Listed on BSE: 539551 and NSE: NH.
Narayana Hrudayalaya reported revenue of ₹7,896.04 Cr for FY 2025-26 (up 44% YoY) based on consolidated financials.
Narayana Hrudayalaya has 10 current directors:
- Emmanuel Rupert - Managing Director
- Devi Prasad Shetty - Whole-Time Director
- Viren Prasad Shetty - Whole-Time Director
- Terri Smith Bresenham - Director
- Kiran Mazumdar Shaw - Director
- Nachiket Mor - Director
- Naveen Tewari - Director
- Nivruti Rai - Director
- Anesh Shetty - Director
- Arunachalam Shankar - Director
The latest financial statements of Narayana Hrudayalaya on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 14 August 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Narayana Hrudayalaya is 29AABCN1685J1Z4, registered in Karnataka. The company has 20 GST registrations in all, of which 11 are active and 9 are cancelled or inactive. Other active GSTINs include 29AABCN1685J4Z1 (Karnataka), 08AABCN1685J1Z8 (Rajasthan), 18AABCN1685J1Z7 (Assam).
The CIN (Corporate Identification Number) of Narayana Hrudayalaya is L85110KA2000PLC027497. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Narayana Hrudayalaya is a listed company as per MCA records. Its shares are listed on both BSE (code: 539551) and NSE (symbol: NH).
Narayana Hrudayalaya has 70 court cases on record: 52 filed by the company and 18 filed against it. 27 are pending. Most are in the high courts.
Narayana Hrudayalaya was incorporated on 19 July 2000, making it 26+ years old. It is registered with the Registrar of Companies, Bangalore.
Narayana Hrudayalaya has 28 deals on record (14 market trades, 6 secondary share transfers, 4 acquisitions), with disclosed funding of ₹606.7 Cr; the latest was in November 2025.
The peers of Narayana Hrudayalaya by revenue are Apollo Hospitals Enterprise Limited, Fortis Healthcare Limited, Max Healthcare Institute Limited, Aster DM Quality Care Limited, Fortis Hospitals Limited and 2 more, all in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (human health activities).
Anesh Shetty was appointed as Director on 15 Jun 2024. Nivruti Rai was appointed as Director on 15 Jun 2024. Arun Seth ceased to be Director on 07 Aug 2023. Narayana Hrudayalaya has 54 board changes on record in total.

